Analyzing Nephros (NASDAQ:NEPH) & INLIF (NASDAQ:INLF)

INLIF (NASDAQ:INLF) and Nephros (NASDAQ:NEPH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership.

Institutional & Insider Ownership

41.1% of Nephros shares are held by institutional investors. 6.7% of Nephros shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations for INLIF and Nephros, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INLIF	1	0	0	0	1.00
Nephros	0	1	1	0	2.50

Nephros has a consensus target price of $6.00, indicating a potential upside of 98.94%. Given Nephros’ stronger consensus rating and higher possible upside, analysts plainly believe Nephros is more favorable than INLIF.

Earnings & Valuation

This table compares INLIF and Nephros”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INLIF	$18.41 million	2.39	-$5.45 million	N/A	N/A
Nephros	$18.79 million	1.71	$1.19 million	$0.11	27.42

Nephros has higher revenue and earnings than INLIF.

Profitability

This table compares INLIF and Nephros’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INLIF	N/A	N/A	N/A
Nephros	6.35%	12.22%	9.38%

Volatility & Risk

INLIF has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, Nephros has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500.

Summary

Nephros beats INLIF on 11 of the 12 factors compared between the two stocks.

About INLIF

INLIF Ltd. is a holding company, which engages in the development of injection molding machine-dedicated manipulator arms. Its products include: Three-axis robot, Five-axis robot and bull head type manipulator. The company was founded on January 4, 2023 and is headquartered in Quanzhou, China.

About Nephros

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.